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Melanocytes, the pigment forming cells of the skin,
form an almost nonproliferating cell population
located to the lowermost part of the epidermis.
Normally melanocytes are not found higher in the
epidermis or in the dermis. Nevi consist of melano-
cytes with altered growth characteristics and localiza-
tion. The common pigmented nevus, a benign skin
lesion, develops when melanocytes proliferate in the
dermo–epidermal junction or in the dermis. Here
we report growth characteristics of in vitro cultured
normal human melanocytes and dermal nevus-
derived melanocytes. As previously reported, nevus
cells have a moderate to high FGF-2 expression
level. Here we demonstrate that dermal nevus cells
The mechanisms of controlling melanocyte growth andlocalization in the skin are not completely understood(Halaban et al, 1992). Normal melanocytes seem tobe dependent on stimulatory factors produced bybasal keratinocytes. According to previously published
data at least one of these factors is fibroblast growth factor-2
(FGF-2) (Halaban et al, 1988). Additional factors that might have
a role in vivo include hepatocyte growth factor/scatter factor, mast/
stem cell factor, and the neuropeptides endothelin-1, 2, and 3
(Halaban, 1996). Most probably melanocyte growth and survival
in vivo requires cooperation of several supporting factors.
Fibroblast growth factors (FGFs) form a family of growth
promoting polypeptides (Baird and Klagsbrun, 1991). FGFs have a
wide variety of functions ranging from mitogenesis and induction
of neovascularization in endothelium to the ability to support the
survival of neurons both in vivo and in vitro (Wilkie et al, 1995).
FGF-2 is one of the most studied members of the family. In spite
of its abundance in mature vertebrate tissues, its mode of function
is not completely known. FGF-2, unlike some of the other members
of the family, does not contain a signal sequence required to guide
proteins to the conventional secretory pathway (Mignatti and
Rifkin, 1991). Accumulating published data point to a novel
secretion mechanism (Piotrowicz et al, 1997). Once outside the
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are able to survive in three-dimensional type 1
collagen culture, while normal human melanocytes
rapidly undergo apoptosis. Melanocytes also, how-
ever, survive in collagen cultures in the presence of
exogenous FGF-2. The survival of nevus cells in
collagen is suppressed by protamine, an inhibitor of
FGF-mediated cell stimulation. The in vivo growth
environment of dermal nevus cells consists largely
of type I and type III collagens. The results suggest
that FGF-2 expression by nevus cells allows them to
adapt to grow in the dermis. FGF-2 obviously has
importance as a melanocyte survival factor and
probably also in the development of malignant
melanoma. J Invest Dermatol 113:111–116, 1999
cell, FGF-2 is quickly bound to its low affinity binding sites (mainly
heparan sulfate proteoglycans) in the extracellular matrix or on the
cell surface. Thus, its activities are probably mainly autocrine and/
or paracrine in nature (Vlodavsky et al, 1987; Saksela et al, 1988;
Saksela and Rifkin, 1991).
It has been shown both immunohistochemically and by in situ
hybridization that practically all nevi express FGF-2 while normal
melanocytes are almost completely negative (Scott et al, 1991).
High FGF-2 levels are very often encountered in melanoma tumors
and cell lines. Acquirement of FGF-2 autocrine activity has been
suggested to be an important step in melanoma progression (Reed
et al, 1994). Both transfection experiments in vitro and the presence
of FGF-2 in nevi show that the growth factor alone is not sufficient
to transform melanocytes (Dotto et al, 1989). On the other hand,
the inhibition of FGF-mediated signaling by expression of antisense-
oriented FGF-2 or FGFR-1 cDNA blocks melanoma tumor growth
(Wang and Becker, 1997). The scope of this paper is to study the
effects of FGF-2 on cultured melanocytes by comparing normal
melanocytes and nevus cells both in conventional and in three-
dimensional growth conditions in vitro.
MATERIALS AND METHODS
Cell culture Human skin melanocyte cultures were established from
normal adult human skin according to a modified selection method
originally described for isolating retinal pigment cells (Hu et al, 1993).
Briefly, most of the dermis was mechanically removed. The remaining
layers were treated with dispase (Collaborative Biomedical Products,
Bedford, MA) for 20 min to separate epidermis from the rest of the dermis.
The epidermis was then treated with trypsin-EDTA for 15 min. The
detached cells were cultivated in a selective F-12 medium containing 10%
fetal calf serum, 1 µg cholera toxin (CT, Sigma, St. Louis, MO) per ml,
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10 ng phorbol 12-myristate 13-acetate (PMA, Sigma) per ml, and 3 ng
human recombinant FGF-2 (a gift from Dr. Andreas Sommer, Synergen,
Boulder, CO) per ml. After the plates had reached about 50% confluence
they were treated with Geneticin (100 µg per ml, Sigma) for 7–10 d to
kill remaining fibroblasts and keratinocytes.
To initiate nevus melanocyte cultures a 3 mm biopsy specimen was
obtained from an excised intradermal or compound-type nevus. The
epidermis was mechanically removed to the depth of the dermal papillary
layer. The superficial part of the remaining dermis was cut into pieces and
collagenase (type XI, Sigma) was used to produce a single-cell suspension.
The cells were plated and treated as above. Both melanocyte and nevus
cell cultures stained 100% positive for S-100 (antibodies from Dako,
Denmark) and GD3 ganglioside (antibodies from Biogenesis, Bournemouth,
UK) after Geneticin treatment with no detectable contamination by
keratinocytes or fibroblasts.
After obtaining informed consent, melanocyte cultures were established
from seven skin biopsies and four nevus biopsies taken from different adult
individuals. Each experiment was repeated at least three times using cells
of different origin. The cells were used between passages 4–12.
Before every experiment the cells were kept in F-12 medium containing
10% fetal calf serum without CT, PMA, and FGF-2 for 24 h (or 48 h
when indicated) and the experiments were carried out in the absence of
these factors unless stated otherwise.
Cell proliferation assay The FGF-2 induced cell proliferation was
measured using CellTiter 96 AQ kit (Promega, Madison, WI) following
the manufacturer’s instructions. The assay is based on conversion of a
tetrazolium compound to a colorimetrically detectable formazan product
by metabolically active cells (Cory, 1991).
Construction of collagen lattices To produce a three-dimensional
collagen gel, acid soluble rat tail collagen (type 1 collagen, 3–4 mg per ml;
Upstate Biotechnology, Lake Placid, NY) was mixed 1:1 with 23 medium.
The gel was allowed to polymerize for 30 min in 37°C. Cells were seeded
on top of the first collagen layer at 25,000–50,000 cells per cm2. They
attached tightly in 30 min. Unattached cells (,5%) were washed away and
a second layer of collagen gel was cast. After solidification of the second
collagen layer, medium was added on top to provide the cells with enough
nutrients during prolonged experiments.
Protamine (Sigma), when indicated, was added to both layers of collagen
and to the covering medium.
When indicated, the first layer of collagen was coated by human
fibronectin or mouse laminin (Collaborative Biomedical Products) by
incubating a 10 µg per ml solution on top of the gel for 30 min in 37°C.
Cells were seeded after rinsing with medium. In a second set of experiments,
fibronectin and/or laminin were added to both collagen layers before
polymerization (final concentration 10 µg per ml).
Northern blotting RNA was extracted from cultured melanocytes
and nevus cells and poly(A)1 RNA was isolated by oligo(dT)-cellulose
(Collaborative Biomedical Products) affinity chromatography using pub-
lished procedures (Schwab et al, 1983). The specimens were electrophoresed
and blotted onto nylon membrane (Pall, Glen Cove, NY) as described
(Alanko et al, 1996). The cDNA probes were labeled with [α-32P] dCTP
(Amersham, Buckinghamshire, UK) using a random priming kit (Pharmacia
Biotech). The FGF-2 probe was synthesized from a 480 bp cDNA (donated
by Dr. Andreas Sommer, Synergen, Boulder, CO) (Sommer et al, 1987).
The FGFR-1 and FGFR-2 probes were synthesized from 1.2 kbp human
cDNA (both provided by Dr. Michael Jaye) (Dionne et al, 1990). The
FGFR-3 and FGFR-4 probes were synthesized from 2.5 kbp and 2.7 kbp
human cDNA, respectively (both provided by Dr. Kari Alitalo, University
of Helsinki, Finland).
Western blotting Cells were lyzed with 1% Triton X-100/2 M NaCI
in phosphate-buffered saline (PBS) in the presence of proteinase inhibitors
(aprotinin, AEBSF, Pepstatin A). The lysate was centrifuged and an aliquot
was taken for protein measurement. Equal amounts of protein were diluted
1:10 (vol:vol) with distilled, deionized water and incubated on an end-
over-end mixer for 16–24 h with Heparin-Sepharose particles (Pharmacia
Biotech). The particles were washed with 1.0 M NaCl and resuspended
in reducing Laemmli sample buffer. The samples were boiled and loaded
on a 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel.
After electrophoresis the proteins were electroblotted onto a nitrocellulose
filter (Schleicher & Schuell, Keene, NH) and FGF-2 was detected by
affinity-purified rabbit polyclonal anti-FGF-2 antibodies (Alanko et al,
1996) followed by biotin-labeled goat antirabbit antibodies and streptavidin-
horseradish peroxidase (HRP) (Dako, Denmark). Visualization of HRP
was performed with enhanced chemiluminescence (ECL) detection reagents
following the manufacturer’s instructions (Amersham).
Hoechst staining The collagen gels were first fixed with 3% paraformal-
dehyde in PBS for 30 min at room temperature. The gels were then
incubated in 1 µg bisbenzimide per ml in PBS (Hoecst 33342, Sigma) for
30 min at room temperature. After thorough rinsing with PBS, the gels
were inspected and photographed with a Leiz fluorescence microscope
under UV illumination. Condensed and fragmented nuclei were counted
and compared to the total count of stained nuclei. A total of 600–1000
nuclei were evaluated in each setting of an experiment.
DNA fragmentation analysis To extract cellular DNA the cells were
first lyzed with 150 mM NaCl, 25 mM EDTA, 0.2% sodium dodecyl
sulfate. Treatment of the lysate with proteinase K (Boehringer, Mannheim,
Germany) was followed by phenol-chloroform extraction and RNAse A
(Sigma) treatment. DNA was precipitated with ethanol and loaded on a
1.8% agarose gel. Hind III-digested bacteriophage λ DNA (MBI Fermentas,
Lithuania) and Msp I-digested pBR322 plasmid DNA (New England
Biolabs, Beverly, MA) were used as markers. After electrophoresis the gel
was stained with ethidium bromide to visualize DNA.
TUNEL staining Apoptotic DNA cleavage was detected in situ by the
TUNEL method (TdT-mediated dUTP-fluorescein isothiocyanate nick
end labeling) (Gavrieli et al, 1992). The collagen gels were fixed with 3.7%
formaldehyde in PBS for 16 h. The gells were washed several times with
water and covered with a labeling mixture containing 1 nM Fluorescein-
12-dUTP (NEN Life Science Products, Boston, MA), dATP (Boehringer),
0.2 U terminal deoxynucleotidyl transferase (Promega) per µl, and 1 3 TdT
buffer (supplied with the enzyme) in water. After 4 h in 37°C the reaction
was stopped by incubating in 23sodium citrate/chloride buffer. After
intensive washing in PBS the gels were mounted in PBS:glycerol (1:1)
and examined with a Leiz fluorescence microscope equipped with the
appropriate fluorescein isothiocyanate filters. Three to five hundred cells
were evaluated for fluorescence in each setting of an experiment.
RESULTS
Both normal skin melanocytes and nevus cells express
mRNA for high-affinity FGF receptors and are responsive
to FGF-2 in vitro Pigment cells were cultured both from normal
human skin and from human nevocellular nevi as described in
Materials and Methods. The cultures were confirmed to be 100%
melanocytes by immunostaining with antibodies against S-100 and
ganglioside GD3 (data not shown), which are widely used as
markers for melanocytes and melanocyte neoplasms (Stefansson
et al, 1982; Hersey, 1991; Barrett and Raha, 1997).
The expression of FGF receptors was verified to confirm that
our cell lines have retained their ability to respond to FGF
stimulation. Northern blots demonstrated expression of FGFR-1
mRNA (Fig 1) but no or very low expression of mRNA coding
for the extracellular domains of FGFR-2, FGFR-3, or FGFR-4
(data not shown). By using a nonradioactive cell proliferation assay,
we could also show that, in the absence of CT and PMA, the
stimulatory effect of FGF-2 on both melanocytes and nevus cells
was minimal (data not shown). Normal melanocyte cultures that
are maintained for several days without stimuli slowly begin to
deteriorate, but FGF-2 alone can effectively counteract this. Nevus
cells, on the contrary, survive also without FGF-2, which only
potentiates their growth. Practically no DNA synthesizing cells
were detected after 24 h staining with 59-bromodeoxyuridine in
normal melanocyte cultures lacking FGF-2 or other stimulants
(data not shown). In the experimental settings described, there
were no apparent differences in the pigmentation of our cells as a
function of proliferation rate.
Nevus-derived pigment cells express significantly higher
amounts of FGF-2 mRNA and protein than normal
melanocytes In situ hybridization and immunohistochemical
studies have suggested that nevus cells express moderate to high
levels of FGF-2 (Scott et al, 1991). We used northern blotting to
study FGF-2 mRNA expression in our cells in different culture
conditions.
The two principal FGF-2 mRNA (3.7 kb and 7.0 kb) were
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Figure 1. Melanocytes and nevus cells express mRNA for FGFR-
1. Melanocytes (Mela) and nevus cells (Nevus) were maintained in
F-12 1 10% fetal calf serum without stimulants or with cholera toxin,
PMA and FGF-2 (1stim.) for 24 h prior to harvesting. The cells
were lyzed and mRNA was isolated by oligo(dT) cellulose affinity
chromatography. Five micrograms of each mRNA sample were
electrophoresed and blotted onto a nylon membrane. FGF-1 and GAPDH
mRNA were detected by radioactively labeled probes and quantitated by
Fuji Phosphoimager. The FGFR-1 probe detected the major 4.4 kb
transcript and a minor, slightly larger band. Fold ind. shows induction of
FGFR-1 mRNA expression normalized against both GAPDH and Mela.
Five micrograms Tera-2 mRNA was used as a positive control.
Figure 2. FGF-2 mRNA is expressed in nevus cells and is further
induced by stimulators of melanocyte growth. Melanocytes (Mela)
and nevus cells (Nevus) were maintained in F-12 1 10% fetal calf serum
without stimulants or with cholera toxin, PMA, and FGF-2 (1stim.) for
24 h prior to harvesting. The cells were lyzed and mRNA was isolated by
oligo(dT)-cellulose affinity chromatography. Five micrograms of each
mRNA sample was electrophoresed and blotted onto a nylon membrane.
FGF-2 and GAPDH mRNA were detected by radioactively labeled probes
and quantitated by Fuji Phosphoimager. The FGF-2 probe detected two
major transcripts at 7.0 kb and 3.7 kb. Fold ind. shows induction of FGF-
2 mRNA expression normalized against both GAPDH and Mela. Five
micrograms bovine capillary endothelial cell (BCE) mRNA was used as a
positive control.
detected in nevus cell preparations. The expression of FGF-2
mRNA was further induced by CT, PMA, and FGF-2 (Fig 2).
Faint bands could also be detected in stimulated normal melanocytes
after an extended period of exposure (data not shown).
All nevus cell preparations investigated appeared by western
blotting to have a high content of protein immunoreactive with
FGF-2 antibodies (Fig 3). Most of the FGF-2-like immuno-
reactivity migrated at 18 kDa, but minor bands could also be
detected at 22 kDa and 24 kDa. Normal melanocytes had barely
detectable levels of FGF-2-like immunoreactivity (migrating at 18,
22, and 24 kDa). Before protein sample preparation the cultures
were maintained for 2 d in growth medium without CT, PMA,
and FGF-2 (in the presence of 10% fetal calf serum) to deplete
most of the exogenous 18 kDa FGF-2.
Figure 3. Western blotting shows that nevus cells have a high content
of protein immunoreactive with FGF-2 antibodies. Melanocytes and
nevus cells were maintained in F-12 1 10% fetal calf serum in the absence
of cholera toxin, PMA, and FGF-2 for 48 h prior to harvesting. The cells
were lyzed and heparin-binding proteins were concentrated by heparin-
Sepharose affinity chromatography. The proteins were separated in a 12%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and blotted
onto nitrocellulose. FGF-2 was detected using affinity-purified polyclonal
antibodies. The migration of a 21 kDa marker is shown. Last lane (r):
0.1 ng recombinant (18 kDa) FGF-2.
Exogenous FGF-2 acts as a survival factor for normal
melanocytes in a collagen type 1 gel Normal melanocytes
grow in the epidermis. Under physiologic conditions they are not
found in the dermis. Dermal connective tissue consists mostly of
collagens, elastin, glycosaminoglycans, and fibroblasts. To imitate
conditions in the dermis, we cultured melanocytes in a three-
dimensional collagen lattice. As described in Materials and Methods,
we seeded the cells between two layers of collagen type I gel to
facilitate easy visualization in one plane. Similar results were also
obtained when the cells were grown on top of a single collagen
gel layer (data not shown).
Normal melanocytes survived poorly in collagen (Fig 4).
Although they initially attached and spread well on collagen, they
soon lost their extensions, rounded up and began to die. Within
5 d about 45%–70% of the normal melanocytes had condensed
and/or fragmented nuclei (Fig 5). Hoechst staining of the cells
revealed various stages of changes associated with apoptosis: loss of
the neurite-like extensions, chromatin condensation, formation of
apoptotic bodies, and, finally, secondary necrosis (Fig 4). DNA
extracted from the cells grown on collagen for 5 d showed a faint
pattern of internucleosomal cleavage (‘ladder’) (Fig 6, lane 3).
DNA cleavage was also demonstrated by TUNEL staining (data
not shown). In quantitation of apoptotic cells TUNEL gave results
almost identical to Hoechst staining, which was preferred because
of its high reproducibility and simplicity. Adding 5 ng FGF-2 per
ml to the growth medium blocked the development of apoptotic
changes. In the presence of FGF-2 only 5%–10% of the cells
showed changes in their nuclear morphology in 5 d (Fig 5) and
internucleosomal cleavage was effectively inhibited (Fig 6, lane 4).
Also the broad spectrum caspase inhibitor Z-VAD-FMK (20 µM)
inhibited the development of apoptotic changes in melanocytes,
although to a somewhat lesser extent (20% 6 5% inhibition after
2 d in collagen; data not shown). CT (1 µg per ml) alone had no
effect, whereas protein kinase C activator PMA (10 ng per ml) was
as effective as FGF-2 in inhibiting apoptosis (data not shown).
Melanocyte apoptosis in collagen is not caused by soluble
factors and cannot be inhibited by fibronectin or laminin As
collagen preparations are not absolutely pure, we wanted to test
whether apoptosis is caused by contaminating factors present in the
collagen. The cells were seeded on conventional cell culture plastic
dishes and covered with a layer of collagen gel. After 5 d in the
absence of CT, PMA, and FGF-2, no acceleration of apoptosis
could be detected when compared with melanocytes grown without
collagen or cells grown inside collagen in the presence of FGF-2
(Fig 7). We also cultured melanocytes covered with a collagen
solution that was disturbed during polymerization to inhibit gel
formation. This, too, was ineffective in causing apoptotic changes
(data not shown).
Fibronectin has been suggested to suppress apoptosis in melano-
cytes (Scott et al, 1997). To test whether fibronectin or laminin
could enhance survival of melanocytes in collagen, we coated the
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Figure 4. Melanocytes and nevus cells in conventional and three-
dimensional culture conditions show differential morphologic
features. Melanocytes (a, c, e, g, h) and nevus cells (b, d, f) were seeded on a
conventional cell culture plate (a, b) or between two layers of collagen type
1 gel (c–h). The cells were grown in F-12 1 10% fetal calf serum in the
absence of stimulants (a–d, g, h), in the presence of FGF-2 (3 ng per ml) (e)
or protamine (5 µg per ml) (f). Five days after seeding the cells were either
photographed using an inverted microscope (a–f) or fixed, stained with
bisbenzimide, and photographed using a fluorescence microscope (g, h). Both
cell types survived well on a conventional plate (a, b) but most of the
melanocytes rounded up and died in collagen (c). When FGF-2 was added,
melanocytes survived (e) as well as nevus cells did without FGF-2 (d). When
protamine was added to nevus cells, the cells rapidly started undergoing
apoptosis (f). The lowermost panels show a higher magnification of Hoechst-
stained melanocytes after 5 d in collagen under phase-contrast (g) and UV
illumination (h). Scale bar: (a) 25 µm; (g) 5 µm.
first layer of collagen with these matrix components (Fig 7) or
added them to collagen before gel formation (data not shown). No
inhibition of apoptosis could be detected in either case.
Figure 5. Hoechst staining of melanocytes on collagen reveals a
time-dependent increase in the proportion of cells showing
apoptotic changes. Melanocytes and nevus cells were seeded between
two layers of collagen type I gel. After 1–5 days the gels were fixed with
paraformaldehyde, and cell DNA was stained with bisbenzimide. The cells
were examined with a microscope under UV illumination. The number
of fragmented and condensed nuclei were counted and compared with the
total number of nuclei. The results are expressed as the percentage of
apoptotic nuclei. e, Melanocytes –FGF; u, melanocytes 1FGF; n, nevus
cells –FGF. Scale bars: 6SD.
Figure 6. Cultivation of melanocytes in collagen gel causes cleavage
of their chromatin producing oligonucleosomal fragments.
Protamine causes similar changes in nevus cells. Melanocytes (Mela) or
nevus cells (Nevus) were seeded on a conventional cell culture plate or
between two layers of collagen type 1 gel. The cells were grown in
F-12 1 10% fetal calf serum in the absence or presence of FGF-2 (FGF;
3 ng per ml) and protamine (P; 5 µg per ml). The cells were lyzed and
treated with proteinase K and RNAse A. DNA was precipitated and loaded
on a 1.8% agarose gel along with molecular weight markers. After
electrophoresis the gel was stained with ethidium bromide. Markers: λ,
Hind III-digested bacteriofage λ DNA; pBR, Msp I-digested pBR322
plasmid DNA.
Nevus cells survive in collagen without added FGF Dermal
collagen is the natural growth environment for dermal nevi. When
we cultured nevus cells in three-dimensional collagen gel, they
survived like normal melanocytes treated with FGF-2 (Figs 4–6,
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Figure 7. Fibronectin and laminin are ineffective in prohibiting
apoptosis of melanocytes in collagen gel. Melanocytes were seeded
between two layers of collagen or under a single layer of collagen gel
(under coll.) in the absence or presence (FGF-2) of 3 ng FGF-2 per ml.
When indicated, the first layer of collagen was coated with fibronectin
(10 µg per ml) or laminin (10 µg per ml) solution before attachment of
cells. The cells were fixed and stained with bisbenzimide 5 d after seeding.
Apoptotic cells were quantitated by counting fragmented and condensed
nuclei and by comparing this to the total number of stained nuclei. The
result is expressed as the percentage of apoptotic nuclei.
Figure 8. Protamine induces apoptosis in nevus cells in collagen
gel. Nevus cells were seeded between two layers of collagen type 1 gel in
the absence (contr.) or presence of different concentrations of protamine (P).
Five days after seeding the cells were fixed and stained with bisbenzimide.
Apoptotic cells were quantitated by counting fragmented and condensed
nuclei and by comparing this with the total number of stained nuclei. The
result is expressed as the percentage of apoptotic nuclei.
lane 6). As previously shown, nevus cells produce large amounts of
FGF-2 themselves. To demonstrate the potential autocrine effect
of FGF-2, we tested whether protamine, an inhibitor of FGF-
mediated cell stimulation (Huang et al, 1993), would have an effect
on their survival. In the presence of 5 µg protamine per ml, nevus
cells also died (Fig 8) with apoptotic changes identical to those
detected in normal melanocytes (Fig 6, lane 7). The effect of
protamine could be overcome by high concentrations of FGF-2
(100 ng per ml; data not shown). A two times higher (10 µg per
ml) concentration of protamine was not toxic to and did not
cause apoptosis in nevus cells grown on cell culture plastic (data
not shown).
DISCUSSION
Melanocytes are neuroectoderm-derived cells that migrate to skin
during an early stage of development. The localization of melano-
cytes in mature skin is extremely tightly controlled. Abnormalities
of melanocyte localization are most often associated with pathologic
states and often serve as a marker of malignant transformation. It
is also noteworthy that abnormally high FGF expression is almost
without exception found in conjunction with altered localization
of melanocytes. Nevus nevocellularis is the most common pigment
lesion of the skin. The total number of nevi seems to be under
genetic control (Easton et al, 1991; Goldgar et al, 1991). In the
nevus, melanocytes can be found at the dermo–epidermal junction
or in the dermis. The connection between benign nevi and
melanoma is a matter of debate. It seems that several inheritable,
mostly yet unidentified, mutations can lead to a tendency to
develop dysplastic features in nevi (Greene, 1997). Dysplastic nevus
(DN) syndrome in turn is clearly a risk factor for melanoma
(Newton-Bishop et al, 1994).
Normal melanocytes in cell culture are highly dependent on
external stimuli for growth and survival. When they are maintained
without stimuli (but in the presence of serum factors) they stop
dividing and slowly begin to deteriorate. Our results show that
in vitro FGF-2 can counteract this alone. It is not entirely clear
what are the supporting factors and/or cells in vivo, but FGF-2
secreted by surrounding keratinocytes probably is of foremost
importance (Halaban et al, 1988). Nevus cells are not dependent on
keratinocyte stimulation. Mitotic figures can be seen in unstimulated
nevi, although much less often than in a dysplastic nevus or
melanoma (Rieger et al, 1993). Nevus cells also have the potential
for rapid growth. This is well demonstrated by nevus melanocytes
that sometimes grow and migrate to the scar tissue formed after
partial excision of a nevus (Arrese Estrada et al, 1990). We show
that – unlike normal melanocytes – nevus cells produce FGF-2.
The presence of an autocrine loop is suggested by the ability of
protamine to revert their superior survival in collagen. Protamine
is an unspecific inhibitor of FGF-2 and many other heparin-binding
growth regulatory substances. It acts by inhibiting the interactions
between these growth factors and heparan sulfates (Bono et al, 1997).
The mechanism by which FGF-2 exerts its positive effect on
melanocyte survival is not clear, yet. Endogenous expression of
FGF-2 has been connected to increased cell survival in several cell
systems, both benign and malignant. NGF, which is induced in
keratinocytes after UV irradiation, upregulates Bcl-2 expression
in epidermal melanocytes, thus rendering them resistant to
UV-induced apoptosis (Zhai et al, 1996). FGF-2, too, has been
shown to cause upregulation of Bcl-2 in many cell types (Karsan
et al, 1997; Wieder et al, 1997). It also induces Mdm2 in fibroblasts,
thus inhibiting p53 function and leading to lower expression of
the proapoptotic Bax protein (Shaulian et al, 1997). The autocrine
antiapoptotic effect of FGF seems to require intact high affinity
FGF receptors and heparan sulfates and, at least in smooth muscle
cells, it can be inhibited by MAP kinase pathway inhibitors (Aviezer
et al, 1997; Miyamoto et al, 1998).
Our results suggest that the extracellular matrix has an important
role in the regulation of melanocyte apoptosis. Previously, some
melanoma cell lines have been shown to be dependent on expression
of certain integrin molecules for their survival in dermal collagen
(Montgomery et al, 1994). Also, fibronectin has been reported to
act as a survival factor for melanoma cells through an integrin-
dependent mechanism (Scott et al, 1991). On the other hand,
transfection studies on NIH 3T3 cells have shown that activation
of an autocrine FGF-2 loop can alter their integrin expression
pattern (Klein et al, 1996). We are currently studying whether
FGF-2 could regulate the expression of certain integrin molecules
essential for survival of benign melanocytes in three-dimensional
collagen. Data have also been presented that protein kinase C
activators like FGF could have a direct effect on the phosphorylation
of pp125FAK that is a signal mediator acting downstream of
integrins (Scott and Liang, 1995).
Our results bring new evidence of the importance of FGF-2 as
a melanocyte growth factor. FGF-2 is prominently expressed in
melanoma tumors (Reed et al, 1994).
Clinical studies to explore possibilities to treat melanoma with
inhibitors of FGF action are underway elsewhere. Transfection of
a dominant negative FGF receptor gene to a mouse melanoma cell
line was shown in a recent publication to suppress its proliferation
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in vitro and its tumorigenicity when injected to nude mice (Yayon
et al, 1997).
In light of these and our own results, we feel it is important to
work to reveal the mechanisms underlying the supportive effects
of FGF-2 and to characterize the differences between normal and
altered melanocytes.
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